Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
172.5 USD | +5.60% | +2.84% | -4.07% |
05-02 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
05-01 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.07% | 9.13B | |
-5.51% | 182B | |
+2.33% | 111B | |
-3.62% | 68.48B | |
+1.52% | 49.69B | |
+8.06% | 44.46B | |
+2.33% | 40.67B | |
+23.35% | 31.22B | |
+0.67% | 26.09B | |
+15.30% | 25.32B |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- Repligen : Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q4 Revenue $108.6M, vs. Street Est of $93.9M